Importantly, CASD1 overexpression could modulate the expression of other O-acetylated gangliosides or sialylated glycosphingolipids (Globo-, Lacto-/Neolacto-series), which could also modify the biological properties of cancer cells. The gene discussed is CASD1; the disease is cancer.